Topic

Cliodhna McDonough is a life sciences lawyer at Fieldfisher.

Emily Lockey, M.D. is a trainee lawyer at Fieldfisher.

Articles

Cliodhna McDonough and Emily Lockey give a UK perspective on the potential pros and cons of the three leading candidates in the COVID-19 vaccine race.

COVID-19: Is the Vaccine Race Over?

Jill Wechsler is Pharm Exec's Washington Corespondent

In unveiling a set of drug price control measures last week, the president displayed his bitterness that vaccine makers failed to announce their success in achieving high efficacy rates for new preventives before the Nov. 3 election. 

Trump’s Revenge on Pharma

Authorities fear distrust of early preventives and complications for ongoing COVID-19 research.

Vaccine Authorization, Distribution Raise Multiple Challenges 

Must maintain trust in face of customary, non-pandemic challenges.

EU Leaders in  High-Stakes Gamble on COVID Responses

Lessons to launch by during a pandemic—or otherwise.

Case Study: A Drug Launch into COVID Headwinds

President-elect Biden has announced initiatives to combat the widening coronavirus pandemic including a 13-member COVID advisory board.

Tackling COVID Top Priority for New Administration 

Iperion Life Sciences Consultancy in Rockville, Maryland in the US. She is a specialist in project management, IDMP and ICSR training and implementation. Iperion, which operates globally, is paving the way to digital healthcare through its proactive support for standardization and by ensuring the right technology, systems and processes are in place to facilitate process innovation.

Lise Stevens explores what difference the ISO IDMP (Identification of Medicinal Products) data standards would have made in a COVID-19 context — in applications ranging from pharmacovigilance adverse event reporting and electronic prescribing to falsified medicines control.

IDMP in a COVID Context

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at jupton@mjhlifesciences.com

The Medical Affairs Digital Strategy Council's Mary Alice Dwyer and Indegene's Sameer Lal talk to Pharm Exec about how digital solutions can help the Medical Affairs function take a leadership role  in ensuring fast, efficient, and meaningful responses to all stakeholders at a time of intense pressure.

Implementing a Customer-Centric Mindset in Medical Affairs

Amid attention on coronavirus, efforts to address the burden of non-communicable diseases are at a critical juncture.

The Interplay Between COVID-19 Pandemic and NCD Epidemic

FDA has published updated Emergency Use Authorization (EUA) requirements for new coronavirus preventives.